High serum sclerostin levels in children with haemophilia A

Keywords: sclerostin; haemophilia A; bone mineral density; receptor activator of nuclear factor-κB ligand; osteoprotegerin; DKK1

[1]  P. Anagnostis,et al.  Bone disease in patients with haemophilia A and B – where are we now? , 2015, Haemophilia : the official journal of the World Federation of Hemophilia.

[2]  C. Annweiler,et al.  Bone mineral density in men and children with haemophilia A and B: a systematic review and meta-analysis , 2014, Osteoporosis International.

[3]  B. Clarke,et al.  Clinical utility of serum sclerostin measurements. , 2013, BoneKEy reports.

[4]  M. Franchini,et al.  Issues in pediatric haemophilia care , 2013, Italian Journal of Pediatrics.

[5]  Roland Baron,et al.  WNT signaling in bone homeostasis and disease: from human mutations to treatments , 2013, Nature Medicine.

[6]  M. Ozdemir,et al.  Evaluation of bone mineral density in Turkish children with severe haemophilia A: Ankara hospital experience , 2012, Haemophilia : the official journal of the World Federation of Hemophilia.

[7]  A. Zallone,et al.  Myeloma cells suppress osteoblasts through sclerostin secretion , 2011, Blood cancer journal.

[8]  R. Engelbert,et al.  Validation of a new pediatric joint scoring system from the International Hemophilia Prophylaxis Study Group: Validity of the hemophilia joint health score , 2011, Arthritis care & research.

[9]  Vicente Gilsanz,et al.  Assessing bone mass in children and adolescents , 2006, Current osteoporosis reports.

[10]  J. Tanner,et al.  Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. , 1976, Archives of disease in childhood.